1. Wendell LC, Levine JM. Myasthenic crisis. Neurohospitalist. 2011; 1:16–22. PMID:
23983833.
Article
2. Kalita J, Kohat AK, Misra UK. Predictors of outcome of myasthenic crisis. Neurol Sci. 2014; 35:1109–1114. PMID:
24497206.
Article
3. Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep. 2016; 65:1–54.
Article
4. Agmon-Levin N, Kivity S, Shoenfeld Y. Influenza vaccine and autoimmunity. Isr Med Assoc J. 2009; 11:183–185. PMID:
19544711.
5. MartÍn Arias LH, Sanz R, Sáinz M, Treceño C, Carvajal A. Guillain-Barré syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015; 33:3773–3778. PMID:
25999283.
Article
6. Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014; 58:1149–1155. PMID:
24415636.
Article
7. McNicholas N, Chataway J. Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination. J Neurol. 2011; 258:1545–1547. PMID:
21336784.
Article
8. Zinman L, Thoma J, Kwong JC, Kopp A, Stukel TA, Juurlink DN. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study. Muscle Nerve. 2009; 40:947–951. PMID:
19902540.
Article
9. Auriel E, Regev K, Dori A, Karni A. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance. Muscle Nerve. 2011; 43:893–894. PMID:
21607970.
Article
10. Hong YH, Kwon SB, Kim BJ, Kim BJ, Kim SH, Kim JK, et al. Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients. J Neurol Sci. 2008; 273:10–14. PMID:
18602121.
Article
11. Cho S, Sohn CH, Jo MW, Shin SY, Lee JH, Ryoo SM, et al. Correlation between national influenza surveillance data and google trends in South Korea. PLoS One. 2013; 8:e81422. PMID:
24339927.
Article
12. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, et al. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep. 2015; 64:10–15. PMID:
25590680.
13. Yoo SY, Kim OS. Comparison of the incidence rate of influenza-like illness between an influenza-vaccinated group and unvaccinated group. J Korean Biol Nurs Sci. 2016; 18:110–117.
Article
14. Song JY, Cheong HJ, Woo HJ, Wie SH, Lee JS, Chung MH, et al. Immunogenicity and safety of trivalent inactivated influenza vaccine: a randomized, double-blind, multi-center, phase 3 clinical trial in a vaccine-limited country. J Korean Med Sci. 2011; 26:191–195. PMID:
21286008.
Article
15. Taylor C, Marathe A, Beckman R. Same influenza vaccination strategies but different outcomes across US cities? Int J Infect Dis. 2010; 14:e792–e795. PMID:
20643569.
Article
16. Influenza vaccines. Wkly Epidemiol Rec. 2005; 80:279–287. PMID:
16171031.
17. Esposito S, Bruno C, Berardinelli A, Filosto M, Mongini T, Morandi L, et al. Vaccination recommendations for patients with neuromuscular disease. Vaccine. 2014; 32:5893–5900. PMID:
25223270.
Article
18. Choi WS, Noh JY, Baek JH, Seo YB, Lee J, Song JY, et al. Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations. PLoS One. 2015; 10:e0098716. PMID:
25815717.
Article